Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KW-3357 in JAAM-defined DIC
NCT01384409Phase 3Terminated
- Sponsor
- Kyowa Kirin
- Start
- Feb 2012
- Primary completion
- Oct 2012
- Countries
- 1
01
Overview
A Phase 3 trial of antithrombin gamma in disseminated intravascular coagulation (DIC), sponsored by Kyowa Kirin. Started Feb 2012; status: terminated.
02
Drugs
antithrombin gamma
03
Conditions
disseminated intravascular coagulation (DIC)
Beyond the preview
Go deeper on NCT01384409.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01384409.